Stock LYRA LYRA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Lyra Therapeutics, Inc.

Equities

LYRA

US55234L1052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.328 USD -1.09% Intraday chart for Lyra Therapeutics, Inc. +0.77% -93.74%
May. 21 Lyra Therapeutics Reduces Workforce to Extend Cash Runway MT
May. 21 Lyra Therapeutics, Inc. Announces Termination of John E. Bishop as Chief Technology Officer, Effective on or About June 20, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lyra Therapeutics, Inc. Announces Termination of John E. Bishop as Chief Technology Officer, Effective on or About June 20, 2024
CI
Lyra Therapeutics, Inc. Announces Board Changes
CI
Lyra Therapeutics, Inc Announces Appointment of Ronan O?Brien as Chief Legal Officer
CI
Insider Buy: Lyra Therapeutics
MT
Insider Buy: Lyra Therapeutics
MT
Lyra Therapeutics Names John Bishop CTO
MT
Lyra Therapeutics, Inc. Announces Appointment of John Bishop as Chief Technology Officer
CI
Lyra Therapeutics Announces Appointment of Richard Nieman, Md, as Chief Medical Officer, Effective July 11, 2022
CI
Insider Buy: Lyra Therapeutics
MT
Lyra Therapeutics, Inc. Appoints Jim Tobin to Board of Directors
CI
Lyra Therapeutics Appoints Harlan W. Waksal as Executive Chairman
CI
Lyra Therapeutics : Names Jason Cavalier Finance Chief
MT
Lyra Therapeutics Announces Appointment of Robert Kern as Chief Medical Officer
CI
Lyra Therapeutics, Inc. Appoints Nancy Snyderman, to the Compensation Committee of the Board
CI
Lyra Therapeutics, Inc. Announces Board Changes
CI
Lyra Therapeutics Announces Pamela Nelson as Senior Vice President of Regulatory Affairs
CI
Laura Edgerly-Pflug Ceases to Be Senior Vice President of Technical Operations of Lyra Therapeutics, Inc
CI
Lyra Therapeutics Announces Robert Richard as Senior Vice President of Research and Development
CI
Lyra Therapeutics Appoints Bradford Smith to its Board of Directors
CI
Lyra Therapeutics, Inc. Announces Dana Washburn as Chief Medical Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LYRA Stock
  4. News Lyra Therapeutics, Inc.
  5. Insiders